W81XWH16D0009-W81XWH20F0253
Delivery Order
Overview
Government Description
COVID-19-FDA EUA ANTIGEN DETECTION- FDA FAST TRACK SEROLOGY ASSAY OPTIMIZATION
Awardee
Awarding Agency
Funding Agency
Place of Performance
Seattle, WA 98109 United States
Pricing
Cost Plus Fixed Fee
Set Aside
Small Business Set Aside - Total (SBA)
Extent Competed
Full And Open Competition After Exclusion Of Sources
Est. Average FTE
34
Analysis Notes
Amendment Since initial award the Potential End Date has been extended from 09/30/22 to 05/31/25 and the Potential Award value has increased 109% from $12,282,844 to $25,655,995.
Inactive NAICS NAICS 541711 is inactive. Any recompete contract will require a different NAICS code and a potentially different small business threshold.
Inactive NAICS NAICS 541711 is inactive. Any recompete contract will require a different NAICS code and a potentially different small business threshold.
Inbios International was awarded
Delivery Order W81XWH20F0253 (W81XWH-20-F-0253)
for Covid-19-Fda Eua Antigen Detection- Fda Fast Track Serology Assay Optimization
worth up to $25,655,995
by Defense Health Agency
in June 2020.
The contract
has a duration of 5 years and
was awarded
through solicitation Development of multiple immunochromatographic test (ICTs) for the rapid diagnosis/detection of infectious diseases (IDs), and biological warfare agent (BWA) related IDs of military significance.
with a Small Business Total set aside
with
NAICS 541711 and
PSC AJ53
via direct negotiation acquisition procedures.
DOD Announcements
Nov 2020:
InBios International Inc., Seattle, Washington, was awarded a $9,804,306 modification (P00001) to contract W81XWH-20-F-0253 for development, design controls, production and analytical studies and clinical trials for rapid human diagnostic component assays for Severe Acute Respiratory Syndrome Coronavirus 2 (SARSCoV-2) infection. Work will be performed in Seattle, Washington, with an estimated completion date of Sept. 30, 2022. Fiscal 2010 research, development, test and evaluation, Army funds in the amount of $9,804,306 were obligated at the time of the award. U.S. Army Medical Research Acquisition Activity, Fort Detrick, Maryland, is the contracting activity.
Status
(Open)
Last Modified 5/8/24
Period of Performance
6/15/20
Start Date
5/31/25
Current End Date
5/31/25
Potential End Date
Obligations
$25.7M
Total Obligated
$25.7M
Current Award
$25.7M
Potential Award
Award Hierarchy
Indefinite Delivery Contract
Delivery Order
W81XWH16D0009-W81XWH20F0253
Subcontracts
Activity Timeline
Opportunity Lifecycle
Procurement history for W81XWH16D0009-W81XWH20F0253
Transaction History
Modifications to W81XWH16D0009-W81XWH20F0253
People
Suggested agency contacts for W81XWH16D0009-W81XWH20F0253
Competition
Number of Bidders
Not Applicable
Solicitation Procedures
Negotiated Proposal/Quote
Evaluated Preference
None
Performance Based Acquisition
Yes
Commercial Item Acquisition
Commercial Item Procedures Not Used
Simplified Procedures for Commercial Items
No
Other Categorizations
Subcontracting Plan
Plan Not Required
Cost Accounting Standards
Exempt
Business Size Determination
Small Business
Defense Program
None
DoD Claimant Code
Services
IT Commercial Item Category
Not Applicable
Awardee UEI
CNJNQ1GMSN55
Awardee CAGE
3KJL6
Agency Detail
Awarding Office
W81XWH W4PZ USA MED RSCH ACQUIS ACT
Funding Office
HT0986
Created By
kelly.r.green.civ@mail.mil
Last Modified By
kelly.r.green.civ@mail.mil
Approved By
kelly.r.green.civ@mail.mil
Legislative
Legislative Mandates
None Applicable
Performance District
WA-07
Senators
Maria Cantwell
Patty Murray
Patty Murray
Representative
Pramila Jayapal
Modified: 5/8/24